SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $17,256,704,124 |
| Positions | 354 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| TSMC | TSM | ADR | $470,167,665 | 984,500 |
| Definium Therapeutics Inc | DFTX | COM | $322,001,783 | 6,845,276 |
| Praxis Precision Medicines Inc | PRAX | COM | $321,079,680 | 959,048 |
| Xenon Pharmaceuticals Inc | XENE | COM | $266,704,101 | 4,418,557 |
| Silicon Motion Technology Corp | SIMO | ADR | $262,022,046 | 786,074 |
| Spyre Therapeutics Inc | SYRE | COM | $248,509,957 | 2,799,166 |
| Crinetics Pharmaceuticals Inc | CRNX | COM | $241,866,078 | 6,463,551 |
| Apogee Therapeutics Inc | APGE | COM | $230,963,606 | 1,740,101 |
| Guardant Health Inc | GH | COM | $230,143,770 | 1,533,985 |
| Planet Labs PBC | PL | COM | $222,671,832 | 6,721,154 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.